Drug Resistance of Head and Neck Cancer
A special issue of Biology (ISSN 2079-7737).
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 559
Special Issue Editor
Special Issue Information
Dear Colleagues,
Drug resistance in head and neck cancer (HNC) remains a major health problem worldwide. Head and neck cancer can arise in the lips, oral cavity, nasal cavity, pharynx, larynx, and salivary glands, and accounts for approximately 890,000 new cases and more than 450,000 deaths each year. The majority of HNC occurs in the oral cavity and approximately 90% of HNC is categorized as head and neck squamous cell carcinoma (HNSCC). Despite the recent advances in therapeutic modalities, the prognosis and 5-year survival rates for patients with advanced, recurrent, and metastatic diseases remain poor due to treatment resistance.
The current standard-of-care for HNC involves surgical removal combined with radiation and chemotherapy (such as cisplatin, carboplatin, or paclitaxel) or an epidermal growth factor receptor (EGFR) targeting immunotherapy, cetuximab. Unfortunately, more than half of locally advanced HNC cases recur or become metastatic following the treatment and no longer respond to the therapy. The mechanism driving the development of resistance to therapy remains an ongoing crucial topic for exploration but is currently understudied.
Multidrug resistance (MDR) and survival mechanisms such as involving enhanced drug efflux, metabolism, noncoding RNAs, and cancer stem cells (CSCs) are known to contribute to the development of drug resistance in HNC. CSCs are subpopulations of cancer cells with stem cell-like properties thought to be responsible for treatment resistance, recurrence, and metastasis. It is generally believed that CSCs can emerge as part of the early cancer evolution or are induced during and following treatment. The mechanism driving the evolution or acquisition of CSCs in HNC is still poorly understood. The current Special Issue will address the current status and future novel directions for understanding drug resistance in head and neck cancer.
Dr. Ali Khammanivong
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- head and neck cancer
- mechanisms of resistance
- cancer stem cells
- metabolism
- drug efflux
- noncoding RNAs
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
